Erectile function is now measured across pooled clinical trials of cell therapy.
Sexual health is one of the most heavily marketed corners of regenerative medicine, which makes the actual research worth knowing cold. There are now multiple meta-analyses pooling clinical trials of intracavernosal cell therapy, with function measured on validated scales rather than testimonials.
Here is what that pooled data shows, the durability caveat that belongs next to it, and why the cause of the problem decides whether any of it applies to you.
Aurenza does not claim that regenerative medicine treats, cures, or reverses erectile dysfunction or any sexual health condition.
Free consultation with a care consultant, many of our care consultants are registered nurses. No sales reps. No receptionist.
What the Research Shows
Sexual health is one of the most heavily marketed corners of regenerative medicine, which makes the pooled clinical data worth knowing cold, because it exists and it is measured on validated scales rather than testimonials.
A 2025 systematic review and meta-analysis in Translational Andrology and Urology pooled 11 studies measuring the International Index of Erectile Function and found a statistically significant overall improvement of roughly 17 points, alongside significant gains in erection hardness scores and objective penile blood-flow measures on Doppler ultrasound. Independently, a 2025 meta-analysis in BMC Urology found significant six-month improvements in IIEF-5, the IIEF erectile function domain, erection hardness, and peak systolic velocity following intracavernosal cell therapy, with no significant publication bias detected and no major adverse events reported across studies.
Systematic reviews of the human trial base, spanning bone marrow, adipose, umbilical cord, and placental cell sources across vascular, diabetic, and post-prostatectomy causes, consistently report safety alongside improvement in validated function scores in most included studies, a picture echoed in dedicated reviews of the human trials.
The Honest Line
The same analyses state the boundary plainly, and so will we. The evidence comes primarily from early-phase studies with small samples, heterogeneous patients, frequent lack of control groups, and short follow-up, and the 2025 pooled analysis rates the overall certainty as low. The BMC Urology analysis is explicit that its significant improvements are at six months, currently the longest follow-up reported across the pooled trials. Six months is the best-supported window; no study shows a guarantee it works every time, that it lasts, or that it will work for you. And because erectile difficulty is frequently an early signal of cardiovascular disease, a review that checks your cardiometabolic picture is sometimes the most valuable thing this entire process produces.
Why This Is Exactly Where a Candidacy Review Comes In
Erectile function sits downstream of blood vessels, nerves, hormones, and medications, and the trial populations were specific. Establishing your actual driver comes first, because it decides whether any of the research above is about you. Every trial above produced its results in selected patients who met specific criteria. That is the gap between "documented in research" and "right for you," and it is the gap a candidacy review exists to close. Before anything is recommended, your bloodwork, biomarkers, imaging, and history are reviewed by a physician panel to establish whether you are actually in the population the research describes. If the picture supports moving forward, you will know exactly why. If it does not, you will be told that, plainly. That is where to start.
Free consultation with a care consultant, many of our care consultants are registered nurses. No sales reps. No receptionist.
What Your Candidacy Review Covers
- 01The likely cause, worked up properly: vascular, neurologic, hormonal, medication-related, or mixed.
- 02Your cardiometabolic markers, given how tightly vascular health and erectile function travel together.
- 03Your hormone panel, since low testosterone and thyroid issues are findings with their own established paths.
- 04Current medications, several common classes of which affect function directly.
- 05Physician panel review, with urology-informed input where the case calls for it.
What to Ask Any Provider
What do you believe is causing my dysfunction, and what workup supports that? Do the trial populations you are citing match my cause? What is being administered, at what verified cell count, and how many treatments are you proposing? What does the data say about how long improvement lasts? What would make me a poor candidate?
The Honest Limits
Individual results cannot be predicted or guaranteed. These applications are not FDA approved, and the procedure takes place in Mexico under COFEPRIS regulation. This page is education for adults researching options; it is not a substitute for evaluation of the cardiovascular and metabolic factors that often underlie sexual health concerns.
Free consultation with a care consultant, many of our care consultants are registered nurses. No sales reps. No receptionist.
Free consultation with a care consultant, many of whom are registered nurses. No sales reps. No receptionist.